Alert detail

CMS Transmittal R13921CP: NCD 210.3 Screening for Colorectal Cancer-Non-Invasive Biomarker Tests

Policy ID: CMS-T-R13921CPSpecialty: Clinical LaboratoryAdded: 8/27/2026Effective: January 4, 2027ncd

Critical

What changed

NCD 210.3 update changes billing for non-invasive CRC screening tests.

Who’s affected: Clinical Laboratory billing teams · Effective: January 4, 2027

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

View subscription plans Create a free account

Audit documentation

Building an audit file?

The Tripwire Audit Pack exports 12 months of Clinical Laboratory policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Clinical Laboratory audit pack — $349One-time purchase · not a subscription

Not ready to subscribe?

Get the free weekly reimbursement brief for Clinical Laboratory— the week’s changes and deadlines, delivered to your inbox. No account required.